Zhejiang Orient Gene Biotech Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 496.32 million compared to CNY 7,100.99 million a year ago. Revenue was CNY 501.54 million compared to CNY 7,111.24 million a year ago.

Net income was CNY 34.81 million compared to CNY 2,741.65 million a year ago. Basic earnings per share from continuing operations was CNY 0.17 compared to CNY 13.6 a year ago. Diluted earnings per share from continuing operations was CNY 0.17 compared to CNY 13.6 a year ago.